The Masked Thalassemia: A Rare Case of a Patient with Normal HbA2 Levels, β-Thalassemia Pathogenic Variant (CD39 C>T), and a Novel δ-Globin Gene Deletion. [PDF]
Chetta M +10 more
europepmc +1 more source
Sickle cell and beta thalassemia: what are the treatment options and challenges? [PDF]
Parliamentary Office of Science and Technology +1 more
openalex +1 more source
Controversies surrounding the effects of beta S-haplotype and alpha- thalassemia-2 on the clinical severity of sickle cell anemia [letter] [PDF]
LS Chan, DR Powars
openalex +1 more source
HemaSphere, Volume 9, Issue 12, December 2025.
Sotiroula Chatzimatthaiou +22 more
wiley +1 more source
Utility and Safety of Romiplostim in Pediatric Allogeneic Stem Cell Transplantation
ABSTRACT Background The use of romiplostim, a thrombopoietin agonist, has increased in the last decade for the treatment of immune mediated thrombocytopenia and severe aplastic anemia. Its utility has been explored in the management of delayed platelet engraftment and secondary platelet failure during stem cell transplant (SCT), but its use has ...
Srividhya Senthil +10 more
wiley +1 more source
Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia. [PDF]
Ouragini H +10 more
europepmc +1 more source
Cellular therapies for sickle cell disease: Should we be calling them a cure?
HemaSphere, Volume 9, Issue 12, December 2025.
Lydia O. Okoibhole +3 more
wiley +1 more source
Assessment of Adherence to Iron Chelation Therapy Among Thalassemia Patients in Palestine. [PDF]
Zabadi HA, Ieran Z, Taha I.
europepmc +1 more source
Characterization and risk assessment of HbF elevation in non-thalassemia hematologic disease patients in Guangdong region. [PDF]
Ge Y +6 more
europepmc +1 more source

